These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17887917)

  • 1. Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality?
    Mancuso M; Coppedè F; Murri L; Siciliano G
    Antioxid Redox Signal; 2007 Oct; 9(10):1631-46. PubMed ID: 17887917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and Alzheimer's disease: new developments.
    Mancuso M; Siciliano G; Filosto M; Murri L
    J Alzheimers Dis; 2006 Jul; 9(2):111-7. PubMed ID: 16873958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1103-10. PubMed ID: 17146283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons.
    Reddy PH
    Antioxid Redox Signal; 2007 Oct; 9(10):1647-58. PubMed ID: 17696767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: a lesson from mitochondrial dysfunction.
    Moreira PI; Santos MS; Oliveira CR
    Antioxid Redox Signal; 2007 Oct; 9(10):1621-30. PubMed ID: 17678440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial aging and dysfunction in Alzheimer's disease.
    Sullivan PG; Brown MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):407-10. PubMed ID: 15795049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of mitochondrial calcium as a pharmacological target for Alzheimer's disease.
    Hung CH; Ho YS; Chang RC
    Ageing Res Rev; 2010 Oct; 9(4):447-56. PubMed ID: 20553970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!
    Cardoso SM; Correia SC; Carvalho C; Moreira PI
    Handb Exp Pharmacol; 2017; 240():281-308. PubMed ID: 28251365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease.
    Moreira PI; Duarte AI; Santos MS; Rego AC; Oliveira CR
    J Alzheimers Dis; 2009; 16(4):741-61. PubMed ID: 19387110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?
    Leuner K; Hauptmann S; Abdel-Kader R; Scherping I; Keil U; Strosznajder JB; Eckert A; Müller WE
    Antioxid Redox Signal; 2007 Oct; 9(10):1659-75. PubMed ID: 17867931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
    Atamna H; Frey WH
    Mitochondrion; 2007 Sep; 7(5):297-310. PubMed ID: 17625988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease.
    Cardoso SM; Pereira CF; Moreira PI; Arduino DM; Esteves AR; Oliveira CR
    Exp Neurol; 2010 Jun; 223(2):294-8. PubMed ID: 19559703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimer's disease.
    Lloret A; Badía MC; Mora NJ; Ortega A; Pallardó FV; Alonso MD; Atamna H; Viña J
    Free Radic Biol Med; 2008 Jun; 44(12):2019-25. PubMed ID: 18387371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology.
    Moreira PI; Carvalho C; Zhu X; Smith MA; Perry G
    Biochim Biophys Acta; 2010 Jan; 1802(1):2-10. PubMed ID: 19853658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.
    Blass JP; Gibson GE
    Rev Neurol (Paris); 1991; 147(6-7):513-25. PubMed ID: 1962057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.
    Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Müller WE
    Exp Gerontol; 2006 Jul; 41(7):668-73. PubMed ID: 16677790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mitochondria: recent pathophysiological discoveries and new therapeutic perspectives].
    Clostre F
    Ann Pharm Fr; 2001 Feb; 59(1):3-21. PubMed ID: 11223575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards Alzheimer's root cause: ECSIT as an integrating hub between oxidative stress, inflammation and mitochondrial dysfunction. Hypothetical role of the adapter protein ECSIT in familial and sporadic Alzheimer's disease pathogenesis.
    Soler-López M; Badiola N; Zanzoni A; Aloy P
    Bioessays; 2012 Jul; 34(7):532-41. PubMed ID: 22513506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.